Role of dexmedetomidine as an anaesthetic adjuvant in breast cancer surgery as a day-care procedure: A randomised controlled study
Conclusion: Dexmedetomidine as an anaesthetic adjuvant makes breast cancer surgery feasible on day-care basis.
Source: Indian Journal of Anaesthesia - Category: Anesthesiology Authors: Rekha Das Rajat Kumar Das Sushrita Sahoo Suchismita Nanda Source Type: research
More News: Anesthesia | Anesthesiology | Bleeding | Breast Cancer | Cancer | Cancer & Oncology | Fentanyl | India Health | Pain | Skin | Statistics | Students | Study | Universities & Medical Training